PhageTech Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $500K

  • Investors
  • 13

PhageTech General Information

Description

Developer of bio-medical sensors designed for rapid and sensitive detection of diseases at their early stages. The company's sensors use bacteriophage bonds to detect analytes in urine, blood, and almost any other body fluid along with cancer and infectious diseases in their earliest stages accurately, enabling physicians to treat patients conveniently and instantaneously.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • 5 Mason
  • Suite 170
  • Irvine, CA 92618
  • United States
+1 (949) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PhageTech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 23-May-2017 $500K 00.00 Completed Clinical Trials - Phase 1
3. Early Stage VC (Series A) 01-Oct-2015 00.00 00.00 Completed Clinical Trials - Phase 1
2. Accelerator/Incubator Completed Clinical Trials - Phase 1
1. Grant $2.2M Completed Clinical Trials - Phase 1
To view PhageTech’s complete valuation and funding history, request access »

PhageTech Executive Team (7)

Name Title Board Seat Contact Info
Rodney Brenneman Chief Executive Officer
Margaret Cate Chief Financial Officer
Reginald Penner Ph.D Co-Founder
Gregory Weiss Ph.D Co-Founder, Chief Scientific Officer & Board Member
You’re viewing 4 of 7 executive team members. Get the full list »

PhageTech Board Members (7)

Name Representing Role Since
Gregory Weiss Ph.D Self Co-Founder, Chief Scientific Officer & Board Member 000 0000
Jack Syage Ph.D Self Board Member 000 0000
Jack Van Berkel Self Board Member 000 0000
Jeff Manassero Self Board Member 000 0000
Paul Cate Mark IV Capital Chairman of the Board 000 0000
You’re viewing 5 of 7 board members. Get the full list »

PhageTech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PhageTech Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Black River Asset Management Hedge Fund Minority 000 0000 000000 0
Collective Capital Ventures Venture Capital Minority 000 0000 000000 0
Domain Associates Venture Capital Minority 000 0000 000000 0
HPE Growth Growth/Expansion Minority 000 0000 000000 0
Jeff Manassero Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »